Trials / Completed
CompletedNCT04929990
The Effect of Respiratory Muscle Training for Patients With COPD and Mild Cognitive Impairment
The Therapeutic Effect of Inspiratory and Expiratory Muscle Strengthening Training on Patients With COPD and Mild Cognitive Impairment
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 70 (actual)
- Sponsor
- Taichung Veterans General Hospital · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Patients with COPD and MCI received either inspiratory muscle training or inspiratory plus expiratory muscle training and compared the therapeutic effects
Detailed description
Patients with COPD and MCI were recruited, and were randomly assigned to the experimental group and the control group. The experimental group consisted of EMT and IMT for a total of 8 weeks, while the control group received IMT only. Outcomes measured and compared in this cohort were diaphragmatic thickness fraction and excursion examined by ultrasound, the dyspnea score of modified Medical Research Council (mMRC), the cognitive score of Mini-Mental State Examination (MMSE), and the score of COPD Assessment Test (CAT). In addition, the pulmonary function test, the cardiopulmonary exercise test, and the physiology performance of six minute walking test were also obtained. We also analyzed the difference of each parameters before and after training in each patient.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Respiratory muscle training | Inspiratory and expiratory muscle training were performed using a breathing trainer (Dofin DT11/14, Galemed Co. Ltd, Taiwan) for 30 minutes a day with a total of eight weeks. Before the training, the MIP and maximal expiratory pressure (MEP) were documented by the best performance of three trials with a digital pressure gauge (GB60, Jitto International Co. Ltd, Taiwan) |
Timeline
- Start date
- 2018-08-07
- Primary completion
- 2021-04-06
- Completion
- 2021-06-02
- First posted
- 2021-06-18
- Last updated
- 2021-06-18
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT04929990. Inclusion in this directory is not an endorsement.